Skip to main content
Premium Trial:

Request an Annual Quote

IBM to Enter DNA Sequencing Field with Nanopore Technology

NEW YORK (GenomeWeb News) – IBM announced today that it is developing a nanoscale DNA sequencer, with the goal of sequencing a human genome at a cost of under $1,000.

The firm is one of several companies or researchers that have been awarded at least $5.7 million from the National Human Genome Research Institute this year to support their efforts in developing technologies for sequencing a human genome at low cost. The grants are part of NHGRI's Revolutionary Genome Sequencing Technologies grant program, which also is known as the "$1,000 Genome" program.

IBM said in a statement that scientists from four fields — nanofabrication, microelectronics, physics, and biology — are working together to "master the technique that threads a long DNA molecule through a three nanometer wide hole, known as a nanopore, in a silicon chip." The firm said that its researchers are working on a process for controlling the rate at which a DNA strand moves through the nanopore so that a reader can accurately decode what is in the DNA.

Though NHGRI has not yet issued a statement regarding the firms and researchers that have received grants under the $1,000 Genome project, it listed the grantees on its database. IBM's Thomas J. Watson Research Center reportedly received $557,000 in FY 2009 for its development efforts on the nanopore system, which the firm calls a "DNA Transistor."

As reported yesterday by GenomeWeb Daily News sister publication In Sequence, other grantees include Ion Torrent Systems, which is a Guilford, Conn.-based start up founded by 454 Life Sciences (now part of Roche) co-founder Jonathan Rothberg. Other firms getting grants included San Diego-based Electronic Biosciences and Sunnyvale, Calif.-based Lightspeed Genomics.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.